Lassa Fever Clinical Trial
Official title:
Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers
This is a randomized and double-blinded within study group, placebo-controlled trial to evaluate the safety, tolerability and immunological profile of INO-4500 administered by intradermal (ID) injection followed by electroporation using the CELLECTRA® 2000 device in healthy adult volunteers.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00992693 -
Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
|
Phase 2 | |
| Completed |
NCT04285034 -
Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever
|
||
| Recruiting |
NCT05868733 -
A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
|
Phase 2 | |
| Terminated |
NCT03889106 -
Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever
|
||
| Active, not recruiting |
NCT04794218 -
A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-LASV-GPC Vaccine in Adults in Good General Heath
|
Phase 1 | |
| Completed |
NCT04907682 -
Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever
|
Phase 2 | |
| Not yet recruiting |
NCT06212336 -
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
|
Phase 2/Phase 3 | |
| Completed |
NCT04093076 -
Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana
|
Phase 1 | |
| Not yet recruiting |
NCT06222723 -
LAssa Fever Adjunct Treatment With DEXamethasone
|
Phase 2 | |
| Recruiting |
NCT03655561 -
Lassa Fever Clinical Course and Prognostic Factors in Nigeria
|